Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000353569-19-000051
Filing Date
2019-08-09
Accepted
2019-08-08 17:50:17
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20190630x10q1.htm   iXBRL 10-Q 1343410
2 EXHIBIT 31.1 qdel-ex31120190630xq21.htm EX-31.1 12914
3 EXHIBIT 31.2 qdel-ex31220190630xq21.htm EX-31.2 12997
4 EXHIBIT 32.1 qdel-ex32120190630xq21.htm EX-32.1 6736
  Complete submission text file 0000353569-19-000051.txt   6647894

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20190630.xsd EX-101.SCH 39830
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20190630_cal.xml EX-101.CAL 94247
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20190630_def.xml EX-101.DEF 176730
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20190630_lab.xml EX-101.LAB 639738
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20190630_pre.xml EX-101.PRE 368159
10 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20190630x10q1_htm.xml XML 1168871
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10961 | Film No.: 191010812
SIC: 2835 In Vitro & In Vivo Diagnostic Substances